DIGITAL CLINICAL SOLUTION
DIGITAL CLINICAL SOLUTION
RegASK announces US$10m Series A Funding Round led by Monograph Capital to accelerate its growth
SINGAPORE, Dec. 15, 2022 /PRNewswire/ — RegASK, a global RegTech SaaS company, today announced it has raised a $10m Series A...
Read moreDIGITAL CLINICAL SOLUTION
ObvioHealth Introduces ObvioGo™, a Next-Generation DCT Platform and Mobile Application Delivering Stronger Evidence
NEW YORK – September 14, 2022 – ObvioHealth, a pioneering virtual research organization (VRO), announces...
Read moreDIGITAL CLINICAL SOLUTION
ObvioHealth Ranked on Inc. 5000’s List of Fastest Growing Private Companies for Second Consecutive Year
NEW YORK, Aug. 16, 2022 /PRNewswire/ — ObvioHealth, a leading global Virtual Research Organization (VRO) pioneering end-to-end decentralized clinical...
Read moreDIGITAL CLINICAL SOLUTION
LIVERFASt can be better than the gold standard liver biopsy, because it can predict mortality and morbidity of patients.
This final part of the video informative series focuses on LIVERFASt, a non-invasive AI...
Read moreDIGITAL CLINICAL SOLUTION
Faster, safer, more accurate trials.
ObvioHealth is pioneering new ways to collect clinical trial data. Their innovative platform seamlessly integrates...
Read more